FFTY:NYE-Innovator IBD® 50 ETF (USD)

ETF | Mid-Cap Growth |

Last Closing

USD 27.24

Change

0.00 (0.00)%

Market Cap

N/A

Volume

0.10M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-15 )

Largest Industry Peers for Mid-Cap Growth

ETFs Containing FFTY

N/A

Market Performance

  Market Performance vs. Industry/Classification (Mid-Cap Growth) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -4.72% 69% C- 31% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -4.72% 69% C- 30% F
Trailing 12 Months  
Capital Gain 0.70% 56% F 45% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 0.70% 56% F 33% F
Trailing 5 Years  
Capital Gain 8.74% 11% F 32% F
Dividend Return 3.42% 17% F 6% D-
Total Return 12.15% 11% F 20% F
Average Annual (5 Year Horizon)  
Capital Gain -1.57% 11% F 25% F
Dividend Return -0.88% 11% F 17% F
Total Return 0.69% 61% D- 17% F
Risk Return Profile  
Volatility (Standard Deviation) 29.82% 22% F 35% F
Risk Adjusted Return -2.96% 11% F 19% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.